...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

"I will sell my 100k + shares for a buck Canadian. If anyone wants them PM me & we will get it done."

fuzzy: Put them up on the OTC for 10 cents US per share and see what happens.

 

Koo

 

 

Share
New Message
Please login to post a reply